BIOXYTRAN, INC (BIXT)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$191,077$246,495$255,822$275,616$417,336$312,903$76,295$16,132
Gross profit$87,098$150,191$120,137$109,639$219,945$190,984$57,221$12,098
Research & development$454,000$112,337$1.1M$1.3M$2.0M$544,519
Operating expenses$1.8M$2.2M$3.8M$2.4M$4.2M$1.3M$1.6M$215,110$397,685$821,470$2.2M$1.4M$2.2M$2.5M$4.5M
Operating income−$1.8M−$2.2M−$3.8M−$2.4M−$4.2M−$1.3M−$1.6M−$215,110−$310,587−$671,279−$2.1M−$1.3M−$2.0M−$2.3M−$4.4M−$329,032
Net income−$2.1M−$2.4M−$4.5M−$2.5M−$4.0M−$2.5M−$1.9M−$296,417−$318,387−$696,756−$2.1M−$1.3M−$1.8M−$2.3M−$4.4M−$336,470−$276,345
Basic EPSper diluted share-$0.02-$0.02-$0.03-$0.02-$0.04-$0.03-$0.02$0.00-$0.01-$0.03-$0.21-$0.30-$0.47-$0.02-$0.06-$0.01
Diluted EPSper diluted share-$0.02-$0.02-$0.03-$0.02-$0.04-$0.03-$0.02$0.00-$0.01-$0.03-$0.21-$0.30-$0.47-$0.02-$0.06-$0.01

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys2$317.2K disclosed value
Sells (SEC code S)0$0.00 disclosed value
2 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Nov 18, 2025Form 4Hoberman Alan MDirectorBuycommon210.0K$0.60$126.0K210.0K
Aug 15, 2024Form 4PLATT DAVIDCEOBuycommon · indirect1.59M$0.12$191.2K21.68M